Percutaneous Image-Guided Treatment of Pediatric Deep-Vein Occlusions

Joseph Reis1, Aaron Bogart1, Giri M Shivaram1

  • 1Department of Radiology, Seattle Children's Hospital, 4800 Sand Point Way NE, Seattle, WA.

Insights

Pediatric venous occlusions can be treated with catheter-directed therapies (CDTs), offering safe and effective recanalization. These treatments prevent acute complications and chronic issues like post-thrombotic syndrome, improving outcomes for hospitalized children.

Area of Science:

  • Vascular Medicine
  • Interventional Radiology
  • Pediatric Thrombosis

Background:

  • Pediatric venous occlusions are increasingly recognized as significant causes of morbidity and mortality, particularly in hospitalized children.
  • Prompt diagnosis and management are crucial for preventing severe complications.

Purpose of the Study:

  • To review the scope, techniques, and outcomes of catheter-directed therapies (CDTs) for acquired systemic deep vein occlusions in pediatric patients.
  • To highlight the importance of timely diagnosis and management strategies.

Main Methods:

  • Review of existing literature on catheter-directed therapies for pediatric venous occlusions.
  • Discussion of diagnostic approaches, underlying thrombotic factors, and interventional techniques.
  • Analysis of acute and chronic outcomes associated with CDT.

Main Results:

  • Catheter-directed recanalization is a safe and effective treatment for selected pediatric patients with venous occlusions.
  • CDTs offer acute benefits, including prevention of pulmonary embolism and end-organ failure.
  • Chronic benefits include prevention of superior vena cava syndrome and post-thrombotic syndrome, alongside long-term vessel patency.

Conclusions:

  • Optimizing outcomes in pediatric venous occlusions requires timely diagnosis, identification of thrombosis causes, and expertise in CDT.
  • CDT is a valuable therapeutic option for both acute and chronic systemic deep vein occlusions in children.
  • Recanalization can provide symptomatic relief and achieve durable vessel patency.